Christopher Griffiths
#85,208
Most Influential Person Now
Researcher
Christopher Griffiths's AcademicInfluence.com Rankings
Christopher Griffithscomputer-science Degrees
Computer Science
#2856
World Rank
#2988
Historical Rank
Machine Learning
#219
World Rank
#222
Historical Rank
Artificial Intelligence
#378
World Rank
#385
Historical Rank
Database
#462
World Rank
#484
Historical Rank
Download Badge
Computer Science
Christopher Griffiths's Degrees
- PhD Computer Science Stanford University
- Masters Artificial Intelligence University of California, Berkeley
Similar Degrees You Can Earn
Why Is Christopher Griffiths Influential?
(Suggest an Edit or Addition)Christopher Griffiths's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global epidemiology of psoriasis: a systematic review of incidence and prevalence. (2013) (1892)
- Secukinumab in plaque psoriasis--results of two phase 3 trials. (2014) (1575)
- Pathogenesis and clinical features of psoriasis (2007) (1405)
- Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (2005) (1002)
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) (947)
- Psoriasis: epidemiology, clinical features, and quality of life (2005) (882)
- Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. (2010) (805)
- Definition of treatment goals for moderate to severe psoriasis: a European consensus (2010) (729)
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials (2015) (706)
- A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction (2005) (684)
- European S3‐Guidelines on the systemic treatment of psoriasis vulgaris (2009) (668)
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial (2017) (656)
- Efficacy and safety of guselkumab, an anti‐interleukin‐23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double‐blinded, placebo‐ and active comparator–controlled VOYAGE 1 trial (2017) (591)
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial (2005) (567)
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (2012) (555)
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. (1989) (495)
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). (2015) (474)
- Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. (1991) (452)
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009 (2009) (442)
- Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid) (1993) (433)
- Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity (2012) (397)
- Long‐term safety of ustekinumab in patients with moderate‐to‐severe psoriasis: final results from 5 years of follow‐up (2013) (363)
- Reduced type I and type III procollagens in photodamaged adult human skin. (1995) (362)
- An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. (2003) (361)
- Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. (1994) (345)
- Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. (2005) (325)
- Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis‐specific stress (1997) (325)
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2015) (311)
- The contribution of perceptions of stigmatisation to disability in patients with psoriasis. (2001) (304)
- Current and future management of psoriasis (2007) (298)
- National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study (2020) (298)
- Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. (1995) (279)
- A classification of psoriasis vulgaris according to phenotype (2007) (278)
- Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality (1999) (268)
- Patients with psoriasis and their compliance with medication. (1999) (265)
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis. (2016) (255)
- A cognitive‐behavioural symptom management programme as an adjunct in psoriasis therapy (2002) (238)
- Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. (2002) (237)
- Psychologic factors in psoriasis: consequences, mechanisms, and interventions. (2005) (228)
- A systematic review of treatments for severe psoriasis. (2000) (226)
- Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. (2003) (222)
- REVIEWCytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization (2000) (220)
- Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. (2003) (220)
- Clearance of psoriasis with low dose cyclosporin. (1986) (215)
- Biological therapies in the systemic management of psoriasis: International Consensus Conference (2004) (214)
- Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. (1992) (208)
- Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. (1990) (207)
- Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. (2008) (205)
- The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update. (1990) (204)
- Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. (1990) (194)
- Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis (1999) (192)
- Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche (2013) (191)
- Clindamycin and rifampicin combination therapy for hidradenitis suppurativa (2006) (191)
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases (2013) (190)
- Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. (2004) (182)
- Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. (1991) (182)
- Comparison of teleconsultations and face‐to‐face consultations: preliminary results of a United Kingdom multicentre teledermatology study (1998) (181)
- A photonumeric scale for the assessment of cutaneous photodamage. (1992) (178)
- Why Some Women Look Young for Their Age (2009) (177)
- Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. (1993) (175)
- Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks (2005) (175)
- Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. (1990) (172)
- Treatment of pyoderma gangrenosum with cyclosporine. (1992) (172)
- What patients with psoriasis believe about their condition. (1998) (170)
- Physical and psychologic measures are necessary to assess overall psoriasis severity. (2001) (168)
- The spectrum of skin disorders in abdominal stoma patients (2000) (168)
- Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease (2007) (167)
- Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. (2008) (166)
- Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
- Rook/Wilkinson/Ebling Textbook of Dermatology (1999) (163)
- Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction. (1999) (162)
- Fibrillin microfibrils are reduced in skin exhibiting striae distensae (1998) (161)
- The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. (2008) (160)
- The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis (2017) (159)
- Ciclosporin in psoriasis clinical practice: an international consensus statement (2004) (158)
- Langerhans cell migration (2000) (156)
- The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. (2004) (155)
- Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). (1989) (152)
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study (2016) (152)
- The Salford Psoriasis Index: an holistic measure of psoriasis severity (2000) (151)
- Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. (2004) (150)
- Adherence to medication in patients with psoriasis: a systematic literature review (2013) (147)
- Environmental risk factors for the development of psoriatic arthritis: results from a case–control study (2007) (147)
- Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage. (1992) (147)
- Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink. (2015) (144)
- The role of neuropeptides in psoriasis (2006) (144)
- Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin (1998) (144)
- Investigation of association of the IL12B and IL23R genes with psoriatic arthritis (2008) (142)
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12‐week randomized, double‐blinded, placebo‐controlled phase 2b trial (2018) (141)
- Natural killer and natural killer-T cells in psoriasis (2002) (140)
- Striae gravidarum in primiparae (2006) (139)
- Challenges and approaches for the development of safer immunomodulatory biologics (2013) (138)
- Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. (2013) (138)
- Alcohol consumption and psychological distress in patients with psoriasis (2007) (137)
- AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. (2014) (137)
- Parastomal pyoderma gangrenosum: clinical features and management. (2000) (136)
- Interventions for chronic palmoplantar pustulosis. (2006) (136)
- Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. (2001) (135)
- Patient‐reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial (2005) (135)
- Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis (2000) (135)
- Development of the PSORIQoL, a psoriasis‐specific measure of quality of life designed for use in clinical practice and trials (2003) (133)
- Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. (2001) (132)
- Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. (1995) (131)
- The effects of cyclosporin A on T lymphocyte and dendritic cell sub‐populations in psoriasis (1987) (130)
- Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient (2004) (129)
- Clinical and genetic differences between pustular psoriasis subtypes (2018) (129)
- Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies (2011) (128)
- Muco‐cutaneous retinoid‐effects and facial erythema related to the novel triazole antifungal agent voriconazole (2001) (128)
- Psychological influences in psoriasis (2001) (127)
- Impaired Langerhans cell migration in psoriasis (2006) (126)
- Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate‐to‐severe psoriasis: a randomized controlled trial (2006) (126)
- Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. (1992) (126)
- Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. (2016) (125)
- The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. (1989) (124)
- Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. (2008) (122)
- Intermittent short courses of cyclosporin (Neoral®) for psoriasis unresponsive to topical therapy: a 1‐year multicentre, randomized study (1999) (122)
- Anti‐E‐selectin is ineffective in the treatment of psoriasis: a randomized trial (2002) (121)
- Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. (2004) (118)
- Damage to skin extracellular matrix induced by UV exposure. (2014) (116)
- Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. (2006) (116)
- Pathological worrying, illness perceptions and disease severity in patients with psoriasis (2000) (116)
- Cytokines and Langerhans cell mobilisation in mouse and man. (2005) (116)
- Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. (1992) (114)
- Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. (2009) (114)
- Tumour necrosis factor‐α induces Langerhans cell migration in humans (1999) (113)
- Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis (2007) (113)
- Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study (2020) (112)
- Guideline for anti-TNF-α therapy in psoriatic arthritis (2005) (112)
- Response of the hypothalamic–pituitary–adrenal axis to psychological stress in patients with psoriasis (2005) (111)
- All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. (1994) (110)
- Differential regulation of retinoic acid receptors and binding proteins in human skin. (1992) (110)
- Tumour necrosis factor‐α‐induced migration of human Langerhans cells: the influence of ageing (2002) (109)
- The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. (2005) (106)
- HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. (2019) (105)
- The global state of psoriasis disease epidemiology: a workshop report (2017) (104)
- A Genome-Wide Association Study Identifies the Skin Color Genes IRF4, MC1R, ASIP, and BNC2 Influencing Facial Pigmented Spots. (2015) (104)
- Stimulus-selective induction of CRABP-II mRNA: a marker for retinoic acid action in human skin. (1993) (104)
- Management of primary cicatricial alopecias: options for treatment (2008) (104)
- Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials (2017) (103)
- Tissue section AFM: In situ ultrastructural imaging of native biomolecules (2010) (103)
- Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. (2012) (101)
- IL‐1β‐induced Langerhans’ cell migration and TNF‐α production in human skin: regulation by lactoferrin (2003) (101)
- The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives (2012) (100)
- Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. (1997) (100)
- Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. (2008) (99)
- Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas. (1989) (99)
- Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis (1999) (98)
- Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double‐blind, placebo‐controlled study (2001) (98)
- Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study. (1990) (97)
- Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. (1998) (96)
- Topical tacrolimus in the management of peristomal pyoderma gangrenosum (2001) (95)
- Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis (2015) (95)
- Topical tretinoin (retinoic acid) improves early stretch marks. (1996) (94)
- How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia (2009) (93)
- Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study (2016) (93)
- Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. (2003) (93)
- Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. (2005) (93)
- Circulating natural killer cells in psoriasis (2003) (90)
- Patient satisfaction with teledermatology is related to perceived quality of life (2001) (89)
- Nailfold video capillaroscopy in psoriasis (2000) (88)
- Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. (2004) (88)
- Differential Expression of Peroxisome Proliferator-Activated Receptor Subtypes During the Differentiation of Human Keratinocytes (1998) (88)
- Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis. (1993) (88)
- Does psychosocial stress play a role in the exacerbation of psoriasis? (2013) (88)
- Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. (1986) (87)
- Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris. (2015) (87)
- Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sézary syndrome. (1989) (86)
- Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. (1993) (85)
- Calcipotriene‐induced improvement in psoriasis is associated with reduced interleukin‐8 and increased interleukin‐10 levels within lesions (1998) (85)
- A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis (2001) (84)
- Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin (2006) (84)
- Exogenous topical lactoferrin inhibits allergen‐induced Langerhans cell migration and cutaneous inflammation in humans (2001) (84)
- Therapeutic strategies for psoriasis (2000) (84)
- Cytokine gene polymorphisms in psoriasis (2001) (83)
- The macrolide immunosuppressants in dermatology: mechanisms of action. (2002) (83)
- Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. (1991) (83)
- Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. (1985) (83)
- Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register (2015) (83)
- Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy (2012) (82)
- Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. (2005) (82)
- Successful treatment of psoriasis improves psoriasis‐specific but not more general aspects of patients' well‐being (2004) (82)
- Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. (2008) (80)
- A pilot study examining mindfulness-based cognitive therapy in psoriasis (2015) (80)
- Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris (2011) (80)
- Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. (2005) (79)
- Epidermal Langerhans cell migration and sensitisation to chemical allergens (2003) (79)
- Patients' strategies for coping with psoriasis (2002) (79)
- Psoriasis Prevalence in Adults in the United States. (2021) (79)
- Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. (1994) (78)
- A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. (2011) (76)
- Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. (1994) (75)
- Clinical features of photodamaged human skin are associated with a reduction in collagen VII (1997) (75)
- Altered claudin expression is a feature of chronic plaque psoriasis (2007) (75)
- Systemic ciclosporin and tacrolimus in dermatology (2007) (75)
- Quality of life measures in psoriasis: a critical appraisal of their quality (1998) (75)
- Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. (2007) (74)
- Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis. (2019) (74)
- An in vivo experimental model for effects of topical retinoic acid in human skin (1993) (73)
- Sulfasalazine improves psoriasis. A double-blind analysis. (1990) (72)
- Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate (2001) (72)
- Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA‐S, a phase 3 study (2019) (72)
- Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) (2018) (71)
- An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. (2012) (70)
- Effects of all-trans retinoic acid and Ca++ on human skin in organ culture. (1993) (70)
- A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents. (2001) (69)
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies (2017) (69)
- Update on the use of ciclosporin in immune‐mediated dermatoses (2006) (69)
- Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials (2018) (69)
- Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation. (1990) (68)
- A novel, web‐based, psychological intervention for people with psoriasis: the electronic Targeted Intervention for Psoriasis (eTIPs) study (2013) (68)
- Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) (2020) (68)
- Recognition of need in health care consultations: a qualitative study of people with psoriasis (2013) (68)
- Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. (2002) (67)
- Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017) (67)
- The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia (2015) (66)
- Methotrexate for psoriasis in the era of biological therapy (2008) (66)
- Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis (2016) (66)
- Lichen planopilaris following hair transplantation and face‐lift surgery (2012) (65)
- Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. (1999) (65)
- Psoriasis, T Cells and Autoimmunity (1996) (65)
- Guideline for anti-TNF-alpha therapy in psoriatic arthritis. (2005) (65)
- Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR (2018) (65)
- Netherton's syndrome: increased likelihood of diagnosis by examining eyebrow hairs (1999) (64)
- Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study (2018) (63)
- Defining cancer risk in dermatomyositis. Part I (2009) (63)
- Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR) (2019) (62)
- Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections (2017) (62)
- Recent advances in cutaneous angiogenesis (2002) (62)
- Maintenance of clinical response and consistent safety profile with up to three years of continuous treatment with guselkumab: results from the VOYAGE 1 and VOYAGE 2 trials. (2019) (61)
- Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes (2009) (61)
- Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID‐19 pandemic (2020) (60)
- Antistreptococcal interventions for guttate and chronic plaque psoriasis: a summarised Cochrane review (2000) (60)
- Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017) (60)
- Divergent beliefs about psoriasis are associated with increased psychological distress. (2004) (60)
- A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey (2018) (59)
- Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial (2010) (59)
- ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasis (2013) (59)
- Nuclear hormone receptors in human skin. (2007) (58)
- Rook's textbook of dermatology, eighth edition (2010) (58)
- Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. (1992) (58)
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 (2021) (57)
- Long‐term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis (2002) (57)
- Illness perception in individuals with atopic dermatitis (2007) (57)
- The role of retinoids in the prevention and repair of aged and photoaged skin (2001) (57)
- Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre (2009) (57)
- A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact (2013) (56)
- A randomized, investigator‐masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis (2006) (56)
- Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases (2005) (56)
- Attentional Bias for Psoriasis-Specific and Psychosocial Threat in Patients with Psoriasis (2003) (55)
- The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. (2013) (54)
- The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab (2008) (54)
- Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle-associated antigen (Ki-67) in mycosis fungoides. (1990) (54)
- Infliximab for the treatment of psoriasis (2006) (54)
- Interventions for photodamaged skin. (2005) (54)
- Evidence for the presence of bacteria in the blood of psoriasis patients (2010) (53)
- T lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon. (1989) (53)
- The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. (2008) (53)
- The global challenge for skin health (2015) (53)
- IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. (2003) (53)
- Skin health in older age. (2014) (52)
- The impact of intrinsic ageing on the protein composition of the dermal-epidermal junction (2016) (52)
- Adherence to medication in patients with psoriasis: a systematic review (2012) (52)
- The role of the microbiome in psoriasis: moving from disease description to treatment selection? (2018) (52)
- The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study (1997) (52)
- Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017) (51)
- Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study (2019) (51)
- Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. (1993) (51)
- Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17‐butyrate cream for the treatment of atopic dermatitis (2002) (51)
- Peristomal dermatoses: a novel indication for topical steroid lotions. (2000) (51)
- Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: a double‐blind, multicentre, randomized, dose‐finding trial (2005) (51)
- Efficacy and safety of continuous versus paused etanercept treatment in patients with moderate-to-severe psoriasis over 54 weeks: the CRYSTEL study (2008) (51)
- Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. (2006) (49)
- Structural and compositional diversity of fibrillin microfibrils in human tissues (2018) (49)
- Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper (2015) (49)
- Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. (2009) (49)
- Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. (2002) (48)
- Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength (2017) (48)
- Cytokine blocking agents in dermatology (2002) (48)
- WHO Model Prescribing Information — Drugs Used in Skin Diseases (1999) (47)
- Naevus sebaceus: a mosaic RASopathy (2014) (47)
- Psoriasis and Treatment: Past, Present and Future Aspects (2020) (47)
- Patient‐reported outcome measures in psoriasis: the good, the bad and the missing! (2015) (46)
- The use of retinoids in the treatment of photoaging (2006) (46)
- Filaggrin null alleles are not associated with psoriasis. (2007) (46)
- P16INK4a Positive Cells in Human Skin Are Indicative of Local Elastic Fiber Morphology, Facial Wrinkling, and Perceived Age. (2016) (46)
- Inflammaging and the Skin. (2020) (46)
- Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender * (2020) (45)
- Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology (2009) (45)
- Trade‐offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists (2006) (45)
- A potential role for endogenous proteins as sacrificial sunscreens and antioxidants in human tissues (2015) (44)
- A cross‐sectional survey of the nature and correlates of sleep disturbance in people with psoriasis (2017) (44)
- Does collapse of immune privilege in the hair‐follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? (2009) (44)
- Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata. (1991) (44)
- Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review (2016) (43)
- Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo. (1993) (43)
- Discordance between facial wrinkling and the presence of basal cell carcinoma. (2001) (43)
- Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis (2016) (42)
- Use of alternative treatments by patients with psoriasis. (1998) (42)
- Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis. (2007) (42)
- Photoageing: the darker side of the sun. (2006) (42)
- Patient Satisfaction with Store-and-Forward Teledermatology (2001) (42)
- Short-term retinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K enzyme activity and immunoreactivity. (1992) (41)
- Oral mucosal keratinocytes express RANTES and ICAM‐1, but not interleukin‐8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings (2003) (41)
- Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity (2005) (41)
- Digital teledermatology for skin tumours: A preliminary assessment using a receiver operating characteristics (ROC) analysis (1999) (41)
- In search of oral psoriasis (2011) (40)
- Psoriasis and Atopic Dermatitis (2017) (40)
- Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults (2020) (40)
- How best to halt and/or revert UV‐induced skin ageing: strategies, facts and fiction (2008) (40)
- ‘In someone's clinic but not in mine’ – clinicians’ views of supporting lifestyle behaviour change in patients with psoriasis: a qualitative interview study (2014) (39)
- Distribution and expression of type VI collagen in photoaged skin (2001) (39)
- Immunopathogenesis and immunotherapy of psoriasis. (1995) (39)
- Acne conglobata and adalimumab: use of tumour necrosis factor‐α antagonists in treatment‐resistant acne conglobata, and review of the literature (2015) (39)
- Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus (2008) (39)
- Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. (1995) (38)
- Pathogenic aspects of cutaneous photoaging (2005) (38)
- A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* (2020) (38)
- Expression of microRNA‐184 in keratinocytes represses argonaute 2 (2013) (38)
- Topical sucralfate in the management of peristomal skin disease: an open study (2000) (38)
- Facial appearance reflects human familial longevity and cardiovascular disease risk in healthy individuals. (2013) (38)
- Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure (2019) (38)
- Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus (1999) (38)
- Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study (2017) (37)
- Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years. (2018) (37)
- Thyrotropin‐releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro (2010) (37)
- Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study. (2020) (37)
- Novel immune‐based therapies for psoriasis (2002) (37)
- Evaluation of educational methods in dermatology and confidence levels: a national survey of UK medical students (2011) (37)
- Genomic-driven insights into changes in aging skin. (2009) (37)
- Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. (2008) (36)
- Stigmatization and psoriasis (2003) (36)
- Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis (2016) (36)
- Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-gamma 1 in retinoic acid-treated human skin. (1992) (36)
- Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland (2012) (36)
- Motivational interviewing‐based training enhances clinicians’ skills and knowledge in psoriasis: findings from the Pso Well® study (2017) (36)
- Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018) (35)
- Aging in Skin of Color: Disruption to Elastic Fiber Organization Is Detrimental to Skin's Biomechanical Function. (2019) (35)
- Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials (2020) (35)
- A comparison of wire brush and diamond fraisesuperficial dermabrasion for photoaged skin (1996) (35)
- Topical photodynamic therapy following excisional wounding of human skin increases production of transforming growth factor‐β3 and matrix metalloproteinases 1 and 9, with associated improvement in dermal matrix organization (2014) (35)
- Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? (2010) (35)
- Differential regulation of tyrosinase activity in skin of white and black individuals in vivo by topical retinoic acid. (1993) (35)
- Association of asymmetrical facial photodamage with automobile driving. (1994) (35)
- Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events (2005) (34)
- Interleukin 17-A inhibition in the treatment of psoriasis (2016) (34)
- Organization of the dermal matrix impacts the biomechanical properties of skin (2017) (34)
- Exacerbation of psoriasis by indomethacin (1987) (34)
- The 2016 International League of Dermatological Societies' revised glossary for the description of cutaneous lesions (2016) (33)
- Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review (2020) (33)
- A Crohn's disease‐associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo‐plantar pustular psoriasis or guttate psoriasis (2003) (33)
- Topical retinoic acid for photoaging: clinical response and underlying mechanisms. (1993) (33)
- Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy. (2015) (33)
- A systematic review of treatments for guttate psoriasis (2001) (33)
- Experience with a gluten free diet in the treatment of linear IgA disease. (1987) (33)
- Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation (2004) (33)
- Ageing significantly impacts the biomechanical function and structural composition of skin (2019) (33)
- The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial (2006) (33)
- Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists (2015) (32)
- A systematic investigation of confirmed autoimmune loci in early‐onset psoriasis reveals an association with IL2/IL21 (2011) (32)
- Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. (2000) (32)
- Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy. (1988) (32)
- Salicyloyl‐phytosphingosine: a novel agent for the repair of photoaged skin (2007) (31)
- Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients (2014) (31)
- Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling (2017) (31)
- Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. (2007) (31)
- The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis (2005) (31)
- Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis (2017) (31)
- Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy. (1992) (31)
- Systemic and local administration of cyclosporine in the treatment of psoriasis. (1990) (30)
- Proteomic analysis of suction blister fluid isolated from human skin (2006) (30)
- Primary care‐based screening for cardiovascular risk factors in patients with psoriasis† (2016) (30)
- Cutaneous leukocyte trafficking and psoriasis. (1994) (30)
- Early‐ and late‐onset psoriasis: a cross‐sectional clinical and immunocytochemical investigation (2016) (30)
- The ICAM‐3/LFA‐1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells (1995) (30)
- The prevalence of thyroid autoantibodies in dermatitis herpetiformis (1988) (30)
- A review and update of the clinical uses of cyclosporine in dermatology. (1991) (30)
- Responsiveness to change and interpretability of the simplified psoriasis index. (2014) (30)
- ‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well® patient materials mixed‐methods feasibility study (2017) (30)
- Can stress reduction interventions improve psoriasis? A review (2013) (30)
- Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. (2014) (29)
- ‘I should have taken that further’ – missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed‐methods study (2015) (29)
- Iron status of patients with alopecia areata (1995) (29)
- Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis (2008) (29)
- Induction of proliferation of growth-inhibited keratinocytes and fibroblasts in monolayer culture by sodium lauryl sulfate: comparison with all-trans retinoic acid. (1991) (28)
- Geographical ancestry is a key determinant of epidermal morphology and dermal composition (2014) (28)
- Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide‐positive nerve fibres (2018) (28)
- Novel approaches to characterize age‐related remodelling of the dermal‐epidermal junction in 2D, 3D and in vivo (2017) (28)
- Langerhans cell mobilization distinguishes between early-onset and late-onset psoriasis. (2010) (28)
- The British Association of Dermatologists guidelines for the management of skin disease (1999) (28)
- Exogenous interleukin‐1β restores impaired Langerhans cell migration in aged skin (2004) (28)
- Chemical consequences of cutaneous photoageing (2012) (28)
- Care of patients with psoriasis: an audit of U.K. services in secondary care (2009) (28)
- Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis (2017) (28)
- Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) (2017) (28)
- Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease (2021) (27)
- Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]. (2009) (27)
- Functional magnetic resonance imaging in dermatology: The skin, the brain and the invisible (2017) (27)
- Biomaterials and Granulomas (1996) (27)
- Primary cicatricial alopecias: a U.K. survey (2012) (27)
- Constitutive absence and interferon-gamma-induced expression of adhesion molecules in basal cell carcinoma. (1990) (27)
- The effects of cyclosporine A on T lymphocyte and dendritic cell subpopulations in psoriasis. (1988) (27)
- Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre (2010) (27)
- Immunotherapy for psoriasis: from serendipity to selectivity (2002) (27)
- Differential expression of elastic fibre components in intrinsically aged skin (2012) (27)
- Danger signals and skin sensitization (2002) (27)
- A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. (2013) (26)
- CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis (2004) (26)
- In vitro and in vivo studies with tetra‐hydro‐jasmonic acid (LR2412) reveal its potential to correct signs of skin ageing (2014) (26)
- The CX3CL1–CX3CR1 system and psoriasis (2006) (26)
- Biological therapy for psoriasis. (2006) (26)
- Pilot study of dual‐wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea (2009) (26)
- Optimal Management of Severe Plaque Form of Psoriasis (2005) (26)
- Therapy for psoriatic arthritis: sometimes a conflict for psoriasis. (1997) (25)
- A European perspective on the challenges of managing psoriasis. (2006) (25)
- Drug Treatment of Photoaged Skin (1999) (25)
- All‐trans retinoic acid compromises desmosome expression in human epidermis (1998) (25)
- Topical retinoids and cutaneous biology (1996) (25)
- Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis (2005) (25)
- Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1 (2020) (25)
- A comparison of intense pulsed light and laser treatment of telangiectases in patients with systemic sclerosis: a within-subject randomized trial. (2014) (25)
- Disseminated dermal dendrocytomas. A new cutaneous fibrohistiocytic proliferative disorder? (1990) (25)
- Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. (2008) (25)
- Psoriasis: the future (2001) (25)
- Psoriasis: the future. (2015) (24)
- Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study (2018) (24)
- CD1 gene expression in human skin. (1993) (24)
- Does message framing affect changes in behavioural intentions in people with psoriasis? A randomized exploratory study examining health risk communication (2018) (24)
- A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis. (2019) (24)
- The risk of post‐operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures (2016) (24)
- Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis (2019) (24)
- Exploring the role of prolactin in psoriasis (2012) (23)
- Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits (2020) (23)
- CO 2 laser vaporization for disfiguring lupus pernio (2002) (23)
- Figurate erythema with bullous pemphigoid: a true paraneoplastic phenomenon? (1999) (23)
- Long-term cyclosporine in the management of psoriasis. (1988) (23)
- Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study (2019) (23)
- The future of biological therapies. (2010) (23)
- Not all spindled‐shaped cells embedded in a collagenous stroma are fibroblasts: recognition of the “collagen‐associated dendrophage” (1990) (23)
- Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies (2014) (23)
- Patient–dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real‐world multinational survey (2018) (22)
- A clinical and histologic mycosis fungoides simulant occurring as a T-cell infiltrate coexisting with B-cell leukemia cutis. (1995) (22)
- Selective proteolysis by matrix metalloproteinases of photo-oxidised dermal extracellular matrix proteins. (2019) (22)
- Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin‐17 (2018) (22)
- Ascomycin: an advance in the management of atopic dermatitis (2001) (22)
- Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis. (1996) (22)
- Severely photosensitive psoriasis: a phenotypically defined patient subset. (2009) (22)
- Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin (2013) (22)
- Phosphoinositide-mediated signal transduction in normal and psoriatic epidermis. (1990) (22)
- Cross-linking of structural proteins in ageing skin: an in situ assay for the detection of amine oxidase activity (2013) (22)
- Cyclosporine A in the treatment of psoriasis: a clinical and mechanistic perspective. (1990) (22)
- Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey* (2020) (21)
- Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis. (1988) (21)
- Incidence and prevalence of psoriasis in Israel between 2011 and 2017 (2019) (21)
- Gougerot-Carteaud still an enigma after all these years. (2002) (20)
- Simple methods for denture identification: a clinical trial. (1988) (20)
- Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study (2020) (20)
- Intestinal permeability in dermatitis herpetiformis. (1988) (20)
- Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis (2016) (20)
- Risk of hospitalization and death due to infection in people with psoriasis: a population‐based cohort study using the Clinical Practice Research Datalink * (2020) (20)
- Pilot study of intense pulsed light for the treatment of systemic sclerosis‐related telangiectases (2012) (20)
- Over-the-counter anti-ageing topical agents and their ability to protect and repair photoaged skin. (2015) (20)
- Curly lusterless hair: anatomic surface changes on transplanted hair shafts. (1993) (20)
- Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic (2020) (20)
- Treatments for chronic palmoplantar pustular psoriasis. (2001) (20)
- Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells. (2015) (20)
- Activation of oral keratinocytes by mercuric chloride: relevance to dental amalgam‐induced oral lichenoid reactions (2001) (20)
- Advances in the use of monoclonal antibodies in cancer radiotherapy. (2000) (20)
- Human in vivo pharmacology of topical retinoids (2004) (20)
- Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials (2019) (19)
- Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens (2005) (19)
- Brain inflammation and psoriasis: a [11C]‐(R)‐PK11195 positron emission tomography study (2016) (19)
- Treatment-Related Restoration of Langerhans Cell Migration in Psoriasis (2013) (19)
- Lipidomics for translational skin research: A primer for the uninitiated (2018) (19)
- Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. (2000) (19)
- Pyoderma gangrenosum masquerading as dermatitis artefacta. (2006) (19)
- Downregulation and altered spatial pattern of caveolin‐1 in chronic plaque psoriasis (2002) (19)
- Long‐term control of recalcitrant psoriasis with combination infliximab and methotrexate (2009) (19)
- Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial (2018) (19)
- Alefacept in the Treatment of Psoriasis in Patients for Whom Conventional Therapies Are Inadequate (2005) (19)
- Lower levels of interleukin‐1β gene expression are associated with impaired Langerhans’ cell migration in aged human skin (2017) (18)
- Non-invasive Imaging of Localised Scleroderma for Assessment of Skin Blood Flow and Structure. (2016) (18)
- Novel systemic therapies for the treatment of psoriasis (2016) (18)
- Failure of reticular erythematous mucinosis to respond to cyclosporine. (1992) (18)
- Psoriasis and diffuse systemic sclerosis: a report of three patients. (2000) (18)
- Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta‐analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland (2018) (18)
- Identification of factors that may influence the selection of first‐line biological therapy for people with psoriasis: a prospective, multicentre cohort study (2017) (18)
- Pattern of response in patients with moderate‐to‐severe psoriasis treated with etanercept (2015) (18)
- Lifestyle and youthful looks (2015) (18)
- Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study (2018) (18)
- An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals (2013) (18)
- Serum insulin‐like growth factor 1 and facial ageing: high levels associate with reduced skin wrinkling in a cross‐sectional study (2013) (17)
- A photonumeric scale for the assessment of atrophic facial photodamage (2018) (17)
- Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE) (2020) (17)
- Diurnal and seasonal variation in psoriasis symptoms (2020) (17)
- Retinoic acid antagonizes basal as well as coal tar and glucocorticoid-induced cytochrome P4501A1 expression in human skin. (1995) (17)
- Inpatient management of psoriasis: a multicentre service review to establish national admission standards (2007) (17)
- Genetic susceptibility to psoriasis: an emerging picture (2009) (17)
- Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 µg/g ointment; no correlation with extent of psoriasis (2003) (17)
- Identification of loci associated with late‐onset psoriasis using dense genotyping of immune‐related regions (2015) (17)
- Unilateral linear syringomata. A case report (1999) (16)
- Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 * (2021) (16)
- The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom (2000) (16)
- Multiple glomus tumours, Coats' disease and basic fibroblast growth factor (1997) (16)
- The association between psoriasis and coeliac disease (2017) (16)
- Cyclophilin content of normal and psoriatic epidermis. (1990) (16)
- Proteomic fingerprints of damage in extracellular matrix assemblies (2020) (16)
- Describing the burden of the COVID‐19 pandemic in people with psoriasis: findings from a global cross‐sectional study (2021) (16)
- A review of tazarotene in the treatment of photodamaged skin (2008) (15)
- Interventions for guttate psoriasis. (2000) (15)
- A comparison of wire brush and diamond fraise superficial dermabrasion for photoaged skin. A clinical, immunohistologic, and biochemical study. (1996) (15)
- Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review† (2019) (15)
- A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial (2018) (15)
- The role of personal models in clinical management: Exploring health care providers' beliefs about psoriasis. (2016) (15)
- Psoriasis: future research needs and goals for the twenty-first century. (2004) (15)
- Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. (2017) (15)
- Associations between UVR exposure and basal cell carcinoma site and histology. (2004) (15)
- Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro (2013) (15)
- Folliculitis decalvans (2001) (15)
- Comparing biological therapies in psoriasis: implications for clinical practice (2010) (15)
- Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes (2015) (14)
- Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT) (2021) (14)
- Papuloerythroderma of Ofuji associated with acute myeloid leukaemia (2003) (14)
- Competency assessment of dermatology trainees in the UK (2004) (14)
- What are the barriers to physical activity in patients with chronic plaque psoriasis?* (2020) (14)
- Psoriasis: background and clinical features (2007) (14)
- Reaching complete or near‐complete resolution of psoriasis: benefit and risk considerations (2017) (14)
- The challenges of assessing patients' medication beliefs: a qualitative study (2017) (14)
- Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk (2019) (14)
- Langerhans cells express human β‐defensin 3: relevance for immunity during skin ageing (2018) (14)
- Psoriasis treatment and management – a systematic review of full economic evaluations (2015) (14)
- A pilot study of the effect of oral 8-methoxypsoralen and intraarticular ultraviolet light on rheumatoid synovitis. (1995) (14)
- Retinoids in the management of non-melanoma skin cancer and melanoma. (1996) (14)
- Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis (2015) (14)
- A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis (2019) (14)
- A novel mutation in IL36RN underpins childhood pustular dermatosis (2015) (14)
- The acceptability and usefulness of mindfulness‐based cognitive therapy for people living with psoriasis: a qualitative study (2015) (13)
- Comprar Rook's Textbook Of Dermatology, 4 Vols. 9ª Ed. | C. Griffiths | 9781118441190 | Wiley (2016) (13)
- Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials (2021) (13)
- Beyond skin: the need for a new approach to the management of psoriasis in primary care. (2012) (13)
- Adapalene 0·1% gel and adapalene 0·1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers (1998) (13)
- An investigation of rheumatoid arthritis loci in patients with early‐onset psoriasis validates association of the REL gene (2013) (13)
- Epicutaneous exposure to proteins and skin immune function (2014) (13)
- International collaboration and rapid harmonization across dermatologic COVID-19 registries (2020) (13)
- Worry and Pathological Worry in Patients with Psoriasis: Cross Sectional and Longitudinal Analyses of the Penn State Worry Questionnaire (PSWQ) in Four Samples of Patients (2005) (13)
- The top 10 research priorities for psoriasis in the U.K.: results of a James Lind Alliance psoriasis Priority Setting Partnership (2019) (12)
- Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography. (2016) (12)
- Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study (2015) (12)
- Noninvasive Measurement of Skin Autofluorescence Is Increased in Patients with Systemic Sclerosis: An Indicator of Increased Advanced Glycation Endproducts? (2012) (12)
- A visual literacy course for dermatology trainees (2017) (12)
- Retinoic acid receptor alpha expression and cutaneous ageing. (2004) (12)
- Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis. (2022) (12)
- Drug therapies in dermatology. (2014) (11)
- Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis (2018) (11)
- Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis (2015) (11)
- Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis (2018) (11)
- Research Techniques Made Simple: Bioinformatics for Genome-Scale Biology. (2017) (11)
- Dermatological conditions in HIV infection. (1987) (11)
- Defining tissue proteomes by systematic literature review (2018) (11)
- The future of sunscreens. (2001) (11)
- No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis (2012) (10)
- Retinoic acid receptor α expression and cutaneous ageing (2004) (10)
- The systemic influence of chronic smoking on skin structure and mechanical function (2020) (10)
- No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patients. (2008) (10)
- Predicting Proteolysis in Complex Proteomes Using Deep Learning (2021) (10)
- A new in vitro assay to test UVR protection of dermal extracellular matrix components by a flat spectrum sunscreen. (2017) (10)
- Communicating Cardiovascular Disease Risk to People with Psoriasis: What Techniques do Practitioners Use? (2016) (10)
- Distinctive clinical and histological characteristics of atrophic and hypertrophic facial photoageing (2020) (10)
- Psoriasis 2 Current and future management of psoriasis (2007) (10)
- Mass spectrometry‐based proteomics reveals the distinct nature of the skin proteomes of photoaged compared to intrinsically aged skin (2019) (10)
- Guttate psoriasis is associated with an intermediate phenotype of impaired Langerhans cell migration (2014) (10)
- Providing lifestyle behaviour change support for patients with psoriasis: an assessment of the existing training competencies across medical and nursing health professionals (2014) (10)
- Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis (2017) (10)
- T-cell-targeted biologicals for psoriasis. (2004) (10)
- Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts (2009) (10)
- Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis (2020) (9)
- Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy (2019) (9)
- Severe erythema multiforme responding to high dose intravenous immunoglobulin therapy (2004) (9)
- Utilizing the hair follicle to dissect the regulation and autocrine/paracrine activities of prolactin in humans. (2012) (9)
- Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol (2000) (9)
- AB0912 Two-year efficacy and safety of guselkumab for treatment of moderate-to-severe psoriasis: phase 3 voyage 1 trial (2018) (9)
- Management of psoriasis in pregnancy: time to deliver? (2010) (9)
- What’s new in psoriasis? An analysis of guidelines and systematic reviews published in 2009–2010 (2011) (9)
- Psoriasis and Psychodermatology (2014) (9)
- Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study (2021) (9)
- More rapid improvement in quality of life with fixed-combination calcipotriene plus betamethasone dipropionate aerosol foam vs. topical suspension (PSO-ABLE study in patients with psoriasis vulgaris) (2016) (9)
- The Greater Patient concept (2007) (9)
- Resetting the research agenda for psoriasis. (2003) (9)
- Lysyl oxidase activity in human skin is increased by chronic ultraviolet radiation exposure and smoking (2017) (9)
- Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis (2013) (9)
- Topical Treatments for Scalp Psoriasis (2012) (9)
- NAP-1/IL-8 immunoreactivity in normal and psoriatic skin. (1991) (9)
- Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis (2014) (9)
- WITHDRAWN: Interventions for photodamaged skin. (2015) (8)
- Paradoxical exacerbation of chronic plaque psoriasis by sorafenib (2016) (8)
- Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis (2020) (8)
- Renal biopsy findings in long‐term cyclosporin treatment of psoriasis (1998) (8)
- An art‐based visual literacy training course to enhance clinical skills in dermatology trainees (2019) (8)
- The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up (2021) (8)
- What’s new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008 (2009) (8)
- Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis (2020) (8)
- Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study (2020) (8)
- Adalimumab for the treatment of psoriasis (2009) (8)
- SAT0052 Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study (2014) (8)
- Immunological mechanisms involved in psoriasis (2004) (8)
- Does p40‐targeted therapy represent a significant evolution in the management of plaque psoriasis? (2012) (8)
- Skin diseases and the dry eye. (1985) (8)
- The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumour necrosis factor‐receptor 1 in psoriasis (2001) (8)
- Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis. (2016) (8)
- The promise and challenges of cell therapy for psoriasis * (2021) (8)
- Understanding the experience of sleep disturbance in psoriasis: a qualitative exploration using the Common‐Sense Model of Self‐Regulation (2019) (8)
- Contact dermatitis from topical auranofin. (1995) (8)
- Progress to Date in Advancing Stratified Medicine in Psoriasis (2020) (8)
- What’s new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009 (2010) (8)
- Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal (2019) (8)
- Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study (2021) (8)
- Peptide location fingerprinting reveals modification‐associated biomarker candidates of ageing in human tissue proteomes (2021) (8)
- IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge (2004) (8)
- Age-related deterioration in the mechanical function of human dermal fibrillin microfibrils (2006) (7)
- Persistence with second-line biologic therapies in patients with psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017) (7)
- Topical auranofin ointment for the treatment of plaque psoriasis. (1995) (7)
- The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data. (2021) (7)
- Dowling Oration delivered at the Royal College of Physicians, London, Friday 5 June 1998. Retinoids: renaissance and reformation (1999) (7)
- Single-cell analysis implicates Th17 to Th2 cell plasticity in the pathogenesis of palmoplantar pustulosis. (2022) (7)
- Erratum: Cellular, immunological and biochemical characterization of topical retinoic acid - Treated human skin (J. Investigative Dermatology, 96(5):699-707) (1991) (7)
- Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis (2021) (6)
- The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository (2021) (6)
- Assessment of topical retinoids for the treatment of Far-East Asian skin. (1998) (6)
- A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial (2020) (6)
- Paradoxical eczema in patients with psoriasis receiving biologics: a case series (2022) (6)
- Heterogeneity of fibrillin‐rich microfibrils extracted from human skin of diverse ethnicity (2020) (6)
- Psoriasis (1986) (6)
- 058 Efficacy of ixekizumab therapy: integrated analysis of 3 double-blind, controlled trials UNCOVER-1, UNCOVER-2, UNCOVER-3 (2016) (6)
- Biologics for psoriasis: current evidence and future use (2012) (6)
- Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise (2016) (6)
- International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. (2022) (6)
- Basal cell carcinoma genetic susceptibility increases the rate of skin ageing: a Mendelian randomization study (2020) (6)
- Markers of health and disease and pigmented spots in a middle‐aged population (2015) (5)
- Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) (2018) (5)
- Dermatology COVID-19 Registries (2021) (5)
- The short‐term effect of levocetirizine on quality of life, stress, and depression in itchy psoriasis patients (2019) (5)
- Retinoids and vitamin D analogues: action on nuclear transcription. (1998) (5)
- Topical retinoic acid induces tyrosinase activity in skin of white individuals in vivo (1992) (5)
- An Examination of the Psychometric Properties and Factor Structure of the Feelings of Stigmatization Questionnaire (2007) (5)
- Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis (2022) (5)
- Learning from disease registries during a pandemic: Moving toward an international federation of patient registries (2021) (5)
- The relationship between PASI and DLQI with itch, stress, and depression: Do we need additional decision‐making tools in psoriasis? (2020) (5)
- Disentangling the effects of circulating IGF-1, glucose, and cortisol on features of perceived age (2015) (5)
- Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials (2020) (5)
- Mobilization of epidermal Langerhans cells – reply from the authors (2000) (5)
- The relationship between sleep disturbance, symptoms and daytime functioning in psoriasis: a prospective study integrating actigraphy and experience sampling methodology. (2020) (5)
- Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis (2019) (5)
- Do English healthcare settings use ‘Choice Architecture’ principles in promoting healthy lifestyles for people with psoriasis? An observational study (2015) (5)
- Gliadins bind to reticulin in a lectin-like manner (2004) (5)
- Psoriasis and the risk of myocardial infarction: A population-based cohort study (2014) (5)
- Improving clinical trial design in psoriasis: Perspectives from the global dermatology community (2011) (5)
- SS.1.1 Decrease activity of DNA demethylase in SSC fibroblast and microvascular endothelial cells: a possible mechanism for persistent SSC phenotype (2012) (5)
- A Reevaluation of the Simplified Psoriasis Index (SPI) Using the Thai Language Version: A Study Examining the Validity, Reliability, and Interpretability of SPI When Used in Translation (2020) (4)
- A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children (2015) (4)
- Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies (2021) (4)
- Developing clinical psychology services in an outpatient dermatology speciality clinic: what factors are associated with non-uptake of the service? (1998) (4)
- Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial (2019) (4)
- 002 Switching treatments of etanercept biosimilar GP2015 with originator product does not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis (2017) (4)
- Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey (2022) (4)
- Cyclosporine A in the treatment of psoriasis: a clinical and mechanistic perspective. (1990) (4)
- Fibulin‐2 and its association with fibrillin‐rich microfibrils in the papillary dermis of photoaged skin (2002) (4)
- Developing a protocol to identify and prioritize research questions for psoriasis: a James Lind Alliance Priority Setting Partnership (2018) (4)
- Therapeutic potential of macrolide immunosuppressants in dermatology (2004) (4)
- Medication beliefs are associated with medication adherence in patients with psoriasis using systemic therapies: findings from the Investigating Medication Adherence in Psoriasis study. (2016) (4)
- Making a ‘point’ about the safe disposal of sharps in patients on biological therapies (2008) (4)
- Interleukin‐17 and interleukin‐23 regulate Langerhans cell migration (2016) (4)
- Novel therapeutic approaches to psoriasis. (1998) (4)
- Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis (2021) (4)
- Remodelling of fibrillin-rich microfibrils by solar-simulated radiation: impact of skin ethnicity. (2020) (4)
- A tooth for an eye: cicatricial pemphigoid and the osteo-odonto-keratoprosthesis. (2010) (4)
- Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease (2021) (4)
- What's new in psoriasis treatment? An analysis of systematic reviews published in 2015 (2018) (4)
- How do dermatologists’ personal models inform a patient‐centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast) (2022) (4)
- Genetic variation across the methotrexate metabolic pathway and its influence upon treatment outcomes in patients with psoriasis. (2007) (4)
- Levocetirizine for the treatment of itch in psoriasis patients: An open‐label pilot study in a real‐world setting (2019) (4)
- Defining trajectories of response in patients with psoriasis treated with biologic therapies (2021) (4)
- Clinical impact of antibodies against ustekinumab in psoriasis: an observational, cross-sectional, multicenter study. (2020) (4)
- Interventions for chronic palmoplantar pustular psoriasis (1999) (4)
- Clinical impact of antibodies against ustekinumab in psoriasis: an observational, cross-sectional, multicenter study. (2020) (4)
- Q&A: Under their skin (2012) (3)
- Efficacy of topical cyclosporin A in the treatment of alopecia areata (1994) (3)
- Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review (2022) (3)
- Streptococcal infection may make psoriasis worse but do antibiotics help? (2004) (3)
- Differential persistence of four biologic therapies for the treatment of moderate-to-severe psoriasis: a prospective observational cohort study from the British Association of Dermatologists Biologic Interventions Register (2015) (3)
- Physical activity is important for cardiovascular health and cardiorespiratory fitness in patients with psoriasis (2021) (3)
- Discordance between facial wrinkling and basal cell carcinoma (2001) (3)
- Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR (2021) (3)
- Modern management of psoriasis. (2005) (3)
- SAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis (2013) (3)
- Liver X receptor β: maintenance of epidermal expression in intrinsic and extrinsic skin aging (2009) (3)
- Influence of menopause and hormone replacement therapy on epidermal ageing and skin biomechanical function (2022) (3)
- Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) (2018) (3)
- Secukinumab has demonstrated efficacy and safety in hard-to-treat anti–tumor necrosis factor α failure patients from the United Kingdom and Republic of Ireland: Results of the SIGNATURE study (2018) (3)
- Patient preferences for stratified medicine in psoriasis: a discrete choice experiment * (2021) (3)
- The role of the microbiome in psoriasis: moving from disease description to treatment prediction? (2018) (3)
- Keeping psoriasis under wraps. (2001) (3)
- Developing clinical psychology services in an outpatient dermatology specialist clinic (1998) (3)
- Infliximab produces a sustained and significant improvement in psoriasis over 50 weeks of continuous therapy. (2005) (3)
- Genetic analysis of PSORS1 single nucleotide polymorphisms in guttate psoriasis and palmoplantar pustulosis. (2002) (3)
- Peptide location fingerprinting reveals modification-associated biomarkers of ageing in human tissue proteomes (2020) (3)
- Muco-cutaneous retinoid-effects and photosensitivity related to the novel triazole antifungal agent voriconazole (2001) (3)
- CHAPTER 1. Photoaging in Caucasians (2019) (3)
- Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis. (2000) (3)
- The IMPACT Programme in Psoriasis: Phase I - Where We Are Now and Future Directions (2015) (3)
- Biologic Agents in Psoriasis: British Association of Dermatologists' Guidelines for Biologic Intervention for Psoriasis 2009 (2011) (3)
- AB0738 DUAL NEUTRALISATION OF INTERLEUKIN (IL)–17A AND IL–17F WITH BIMEKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 60-WEEK RESULTS FROM A RANDOMISED, DOUBLE-BLINDED, PHASE 2B EXTENSION STUDY (2019) (3)
- Topical retinoic acid for photoaged skin: Therapeutic effects and mechanisms (1996) (3)
- Expression of the myelomonocytic antigens L1 and CD36 in human epidermis (1990) (3)
- Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study * (2021) (3)
- Persistence with biologic therapies for the treatment of moderate to severe psoriasis: a prospective observational study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2014) (3)
- An evaluation of dermatology patients shielding during the COVID‐19 outbreak (2020) (3)
- 28095 Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment (2021) (3)
- Development of clinical diagnostic criteria for chronic plaque psoriasis: an international e‐Delphi study (2021) (3)
- Ixekizumab for psoriasis – Authors' reply (2016) (3)
- Reduced cutaneous CD200:CD200R1 signaling in psoriasis enhances neutrophil recruitment to skin (2022) (3)
- Erratum: Investigation of association of the IL12B and IL23R genes with Psoriatic Arthritis (2012) (2)
- Cyclosporin A does not inhibit epidermal growth at therapeutic levels. (1988) (2)
- Collagen VII in photoaged skin. (1995) (2)
- O11. Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis (2015) (2)
- Topical PDT following excisional wounding of human skin increases production of TGF-β 3 , MMP-1 and MMP-9 with associated improvement in dermal matrix organisation (2015) (2)
- ‘Brooke of Manchester’ (2000) (2)
- Existing self-report tools are not suitable for measuring adherence to topical therapies in psoriasis (2014) (2)
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases (2023) (2)
- The Skin Science Foundation: Promoting Skin Health through Research. (2020) (2)
- Research priorities and identification of a health‐service delivery model for psoriasis from the UK Psoriasis Priority Setting Partnership (2020) (2)
- Alemtuzumab and chronic plaque psoriasis (2013) (2)
- Practical experience with biologic drug therapies for the treatment of psoriasis in a UK tertiary referral centre. (2008) (2)
- Long‐term, real‐world efficacy of biologics for psoriasis: a single centre's experience (2019) (2)
- Effect of immunogenicity on efficacy of long-term treatment of rheumatoid arthritis with adalimumab (2014) (2)
- Tumour necrosis factor antagonists (2015) (2)
- Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure (2022) (2)
- IRON STATUS OF PATIENTS WITH ALOPECIA AREATA. AUTHORS' REPLY (1995) (2)
- Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy (2022) (2)
- Immunotherapy of Psoriasis (1997) (2)
- Keratinocytes derived from late‐onset‐psoriasis skin do not impair Langerhans cell migration (2018) (2)
- Future therapeutic directions for the treatment of psoriasis. (2009) (2)
- Early and late onset psoriasis (2016) (2)
- 639 The impact of ageing and chronic sun exposure on the biomechanical function and histological composition of black African-American skin (2017) (2)
- Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study (2021) (2)
- Retinoid pharmacogenetics and vasular endothelial growth factor in chronic plaque psoriasis. (2005) (2)
- Efficacy of patient isolation for the control of MRSA in the acute hospital setting: a systematic review (2002) (2)
- IVIG for PG. (2001) (2)
- A QUESTIONNAIRE STUDY OF PATIENTS’ EXPERIENCE DURING NON- (2005) (2)
- Apolipoprotein E polymorphisms and psoriasis. (2004) (2)
- European Society for Dermatological Research (ESDR): Shifting Scope and Expanding Boundaries, Promoting Cutaneous Biology Research across Europe and beyond. (2017) (2)
- Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey (2021) (2)
- Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis 1 1 Disclosure not available at press time. (2004) (2)
- An investigation into the blood‐flow characteristics of telangiectatic skin lesions in systemic sclerosis using dual‐wavelength laser Doppler imaging (2009) (2)
- Papulosquamous disease (2016) (2)
- Prevalence of Atrophic and Hypertrophic Skin Ageing Phenotypes: A UK-based Observational Study (2020) (2)
- WITHDRAWN: Antistreptococcal interventions for guttate and chronic plaque psoriasis. (2019) (1)
- Cicatricial alopecias: a retrospective analysis of 92 cases from one U.K. centre (2010) (1)
- Risk of major adverse cardiac events associated with biologic therapies in patients with plaque psoriasis: systematic review and meta-analysis of randomised controlled trials (2016) (1)
- Communicating cardiovascular disease risk factors to people with psoriasis: What techniques do practitioners use? (2014) (1)
- The Risk of Alcohol-Related Mortality in Patients with Psoriasis: A Population-Based Cohort Study Using Linked Primary Care, Hospital and Mortality Records (2016) (1)
- Differential expression of elastic fibre components in intrinsically aged skin (2011) (1)
- Advances in immunotherapy for psoriasis (2003) (1)
- The UVA component of solar simulated radiation differentially degrades dermal proteins associated with photoageing (2012) (1)
- So you want to be a clinical academic. (2012) (1)
- Molecular structure and function in ageing elastic fibres (2007) (1)
- [Cell movement in the skin]. (1992) (1)
- In search of the source of hyperprolactinaemia in systemic lupus erythematosus. (2011) (1)
- The cause of dermatitis herpetiformis. (1987) (1)
- Characterization of ZNF313/RNF114 as a novel psoriasis susceptibility gene (2008) (1)
- Dr. Murray, et al reply (1976) (1)
- Psoriasis: ten misconceptions. (2004) (1)
- What people think and do about their psoriasis medication: A think-aloud study of treatment adherence and medication beliefs (2012) (1)
- Topical Retinoids -Pharmacological, Cellular and Molecular Aspects1 (1991) (1)
- How does the International League of Dermatological Societies promote skin health for the world? (2019) (1)
- Meeting Report: Psoriasis Stratification to Optimise Relevant Therapy Showcase. (2021) (1)
- Thioredoxin inhibits epidermal Langerhans’ cell (LC) migration in man and mouse (44.6) (2010) (1)
- 72. Systemic Therapy (2008) (1)
- 26750 Cumulative clinical benefits of biologic treatments for psoriasis over 1 year (2021) (1)
- Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study (2022) (1)
- Content development and refinement for a new Patient reported outcome measure for Psoriasis Treatment (PROMPT) (2015) (1)
- Flat spectrum sun screen protects against ultraviolet radiation induced damage to key extracellular matrix components in vitro (2012) (1)
- The International Psoriasis Council: advancing knowledge, enhancing care. (2015) (1)
- Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis of six randomised trials (2020) (1)
- PSS7 - QUALITY OF LIFE IMPROVEMENTS IN PSORIASIS WITH SECUKINUMAB IN A DIFFICULT TO TREAT POPULATION OF ANTI-TNF ALPHA FAILURE PATIENTS FROM THE UK AND REPUBLIC OF IRELAND (2018) (1)
- P98: Biologic‐induced photosensitivity: a case of three (2022) (1)
- PSS74 - PATIENT QUALITY OF LIFE AND SATISFACTION IN AN APREMILAST-TREATED PSORIASIS POPULATION: ANALYSIS OF 126 PATIENTS FROM THE APPRECIATE STUDY IN THE UNITED KINGDOM AND IRELAND (2018) (1)
- Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme (2022) (1)
- Systems medicine and psoriasis (2017) (1)
- Psoriasis shows no association with filaggrin-null alleles (2007) (1)
- A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, Bangladesh (2020) (1)
- Fumaric acid esters for severe recalcitrant psoriasis. (2002) (1)
- Real-world experience with apremilast in patients with psoriasis: interim analysis of 104 patients from the APPRECIATE study (2017) (1)
- Advocacy for a shared physician/patient approach for the management of acne, rosacea, seborrheic dermatitis and photodamage (2022) (1)
- Psychiatric morbidity and suicidal behaviour in psoriasis (2019) (1)
- A 62‐year‐old man presenting with widespread nodulo‐ulcerative cutaneous lesions (2001) (1)
- Progress in psoriasis. Psoriasis: from gene to clinic. London, UK, 5-7 December 1996. (1997) (1)
- Comparison between radiological and histopathological diagnoses in a multicentre international brain tumour magnetic resonance database (2002) (1)
- Use of intrinsic-susceptibility magnetic resonance imaging to assess acute tumor response to the vascular-targeting agent ZD6126 (2004) (1)
- Computer-Based MR Spectroscopy-Assisted Diagnosis of Brain Tumours (2001) (1)
- GMDP and psoriasis (1998) (1)
- Damaging alleles affecting multiple CARD14 domains are associated with palmoplantar pustulosis. (2022) (1)
- Commentary: Biologics for psoriasis: steps to heaven 17 (2012) (1)
- Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2014) (1)
- Ciclosporin in psoriasis consensus statement: reply from authors (2005) (1)
- A painful spot on the nose (1998) (1)
- Reply to ‘Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials’: reply from the authors (2017) (1)
- 14020 Durability of responses with bimekizumab, a selective dual inhibitor of interleukin-17A and -17F, in moderate to severe chronic plaque psoriasis in a 60-week randomized, double-blinded, phase 2b study (BE ABLE 2) (2020) (1)
- Understanding treatment decision-making within the context of self-regulatory failure: A qualitative study in people with psoriasis (2013) (1)
- Can skin aging contribute to systemic inflammaging? (2021) (1)
- Keloidal scleroderma (2003) (1)
- Celebrating the 50th Anniversary of ESDR. (2020) (1)
- Clinical and photobiological characteristics of patients with photosensitive psoriasis. (2006) (1)
- Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation. (1990) (1)
- A quasquicentennial reflection on psoriasis (2014) (1)
- Persistence and effectiveness of systemic therapies for psoriasis (2019) (1)
- A survey of sleep disturbance in psoriasis (2016) (1)
- A multidimensional overview of the burden of psoriasis (2018) (1)
- Secukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment (2018) (1)
- A common pathway for age-related protein oxidation and photoageing (2011) (1)
- Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial (2021) (1)
- 024 Psoriasis Stratification to Optimise Relevant Therapy (PSORT): Clinical and demographic predictors of biologic response for psoriasis (2016) (1)
- 509 Association between biologics and major cardiovascular events in adult patients with plaque psoriasis: A cohort study in the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018) (1)
- Guidelines for Logbook for registration of training activities in dermatology and venereology: report from the Board of Dermatology and Venereology (2007) (1)
- 062 Stress perception impacts on clinical signs of skin ageing and modifies the epigenome (2016) (1)
- Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis (2017) (1)
- 087 International Rare and Severe Psoriasis Expert Network (IRASPEN) – A prospective multi-centre pustular psoriasis registry with genotype-phenotype correlation (2021) (1)
- Medication non‐adherence: the hidden problem in clinical practice (2017) (1)
- Selective immunotherapy for psoriasis (1998) (1)
- Erratum: Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose? (Experimental Dermatology (2005) vol. 14 (70-80)) (2005) (1)
- Impact of biological therapies on risk of major adverse cardiac events in patients with psoriasis: a meta-analysis of randomised controlled trials (2016) (1)
- Treatment Options for Photodamaged Skin (1997) (1)
- Measuring the societal impact of psoriasis in the United Kingdom through a non‐interventional study of patients (2018) (1)
- Oxford Textbook of Rheumatology: The Skin and Rheumatic Disease (2013) (1)
- 13065 More moderate levels of disease severity at baseline related to achievement of treatment targets with apremilast: Results from a pooled analysis (2020) (0)
- 571 Establishing a ‘gold standard’ skin proteome (2016) (0)
- Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis (2023) (0)
- Controversies in Experimental Dermatology (2005) (0)
- P037 The NIHR IMID Bioresource: a descriptive analysis of the first 5000 participants (2023) (0)
- A rapid access clinic for psoriasis: first experiences (2022) (0)
- Access to psoriasis treatment in Brazil and Chile: A cross-sectional multi-centre `Global Healthcare Study on Psoriasis. (2023) (0)
- Development and evaluation of the IMPACT programme patient resources to increase understanding of psoriasis and its management: a mixed-methods feasibility study (2016) (0)
- Risankizumab vs. ustekinumab for plaque psoriasis (2019) (0)
- British Cosmetic Dermatology Group (2017) (0)
- 299 Fibroblasts from aged human skin show an augmented pro-inflammatory response to TLR4 stimulation compared to young fibroblasts (2016) (0)
- 33011 Prevalence, comorbidities and mortality of generalized pustular psoriasis (GPP): A literature review (2022) (0)
- Advocacy for a shared physician/patient approach for the management of acne, rosacea, seborrheic dermatitis and photodamage (2022) (0)
- Genetic analysis of PSORS1 single nucleotide polymorphisms (SNPs) in late onset, guttate and palmoplantar pustular psoriasis. (2003) (0)
- Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2. (2021) (0)
- The role of illness beliefs in disrupted sleep in people with psoriasis (2016) (0)
- Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population‐based cohort study using electronic health data routinely captured in the Teleprimary Care (TPC ®) clinical information system from 2010 to 2020 (2022) (0)
- Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials (2020) (0)
- Imsidolimab, an Anti-IL-36 Receptor Monoclonal Antibody for the Treatment of Generalised Pustular Psoriasis: Results from the Phase 2 GALLOP Trial. (2023) (0)
- Infliximab and risk of serious infection in patients with psoriasis (2019) (0)
- Completeness of reporting of overnight hospitalisations to a psoriasis pharmacovigilance register and the National Health Service Wales Informatics Service. (2017) (0)
- A Real World Comparison of Methods for Assessing Dosing Patterns of Biologic Therapies for Psoriasis (2016) (0)
- Role of memory effector T lymphocytes in the early phase of photosensitive psoriasis. (2006) (0)
- PRE-TREATMENT TMPT PHARMACOGENETIC TESTING AND RISK OF NEUTROPAENIA IN PATIENTS TREATED WITH AZATHIOPRINE: RESULTS FROM THE TPMT AZATHIOPRINE RESPONSE TO GENOTYPING AND ENZYME TESTING (TARGET) TRIAL (2009) (0)
- Predicting and validating protein degradation in proteomes using deep learning (2020) (0)
- Anti-TNF drugs in psoriasis and IBD - Where are we going? (2006) (0)
- The tight junction protein claudin 1 is reduced in photoaged human epidermis (2010) (0)
- British Photodermatology Group: Summaries of Papers (2006) (0)
- Systematic Review of Pharmacogenomics in Psoriasis (2013) (0)
- Issue Information (2020) (0)
- Do the brains of patients with psoriasis exhibit neuroinflammation (2014) (0)
- Exploring Psoriasis Patients’ Experiences of Cardiovascular Disease Risk Discussions With Primary Care Practitioners: a Qualitative Study. (2014) (0)
- Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023) (0)
- Topical retinoic acid for hyperpigmented lesions associated with photoaging in Japanese and Chinese (1993) (0)
- Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis (2021) (0)
- Restoration of collagen and elastic fibre networks following treatment of photoaged skin with Serènesse, a novel over‐the‐counter anti‐ageing product (2021) (0)
- Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: A drug utilisation study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). (2023) (0)
- The IMPACT Pso Well® practitioner training: motivational interviewing and psoriasis management (2016) (0)
- A Crohn's syndrome-associated insertion polymorphism (3020incC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustulosis (PPP) or guttate psoriasis. (2002) (0)
- Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 (2021) (0)
- A propensity-score weighting approach to compare registry and trial populations of patients with psoriasis on biologic therapies (2018) (0)
- The composition of the dermal-epidermal junction is significantly altered in intrinsically aged skin (2014) (0)
- Polymorphisms predictive of outcomes of methotrexate therapy in rheumatoid arthritis are not transferable to patients with psoriasis (2008) (0)
- Translating visual literacy to dermatology training (2017) (0)
- Neural correlates for itch processing: a functional magnetic resonance imaging study (2008) (0)
- Early onset psoriasis is associated with SNPs in the PTPN22 region. (2007) (0)
- Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis (2022) (0)
- 15287 Comparisons of symptom-free and sign-free status among patients with moderate to severe plaque psoriasis treated with guselkumab or adalimumab: Results from VOYAGE 1 (2020) (0)
- Efalizumab: A viewpoint (2005) (0)
- The use of biologic therapies for the treatment of moderate-to-severe psoriasis in UK clinical practice (2008) (0)
- Validation of a teledermatology system in the UK: Preliminary results from the Manchester arm of the UK Multicentre Teledermatology Trial (1997) (0)
- Identifying medication belief groups in psoriasis: a latent profile analysis (2017) (0)
- Psoriasis and the risk of stroke: A population-based cohort study using the Clinical Practice Research Datalink (CPRD) (2014) (0)
- Epidermal and dermal abnormalities. (2002) (0)
- Understanding adherence to treatment in psoriasis patients: A qualitative application of the Necessity-Concerns framework (2013) (0)
- Main Plenary Sessions (2017) (0)
- Tumour necrosis factor α modulates human epidermal langerhans cell frequency (1998) (0)
- British Photodermatology Group (2020) (0)
- Adherence to medication and lifestyle behaviour change in psoriasis: a systematic review (2011) (0)
- Developing a protocol to identify and prioritize research questions for psoriasis: a James Lind Alliance Priority Setting Partnership (2018) (0)
- Comprar Surface and Interfacial Forces | Tony Burns | 9783527408498 | Wiley (2010) (0)
- In vivo susceptibility contrast MRI of murine models of liver metastasis (2004) (0)
- Su.49. Pleiotropic Susceptibility Loci Identified in Psoriasis, Type II Diabetes and Crohn's Disease (2008) (0)
- A skin disease survey of the Maasai in North Eastern Tanzania. (2022) (0)
- BI01: Dupilumab in the management of atopic dermatitis in an immunosuppressed renal transplant patient (2022) (0)
- The role of Malassezia yeast in seborrheic dermatitis (1998) (0)
- Association of apolipoprotein E polymorphisms with psoriasis. (2004) (0)
- Migrant skin health - Perspectives from the Migrant Health Summit, Malta, 2022. (2023) (0)
- 238 Retinol at a concentration of 0.3% restores fibrillin-rich microfibrils and modifies the epidermis in photoaged human skin in vivo in a manner similar to 1% retinol (2020) (0)
- 306 and function of keratins in the nucleus (2016) (0)
- Diurnal and seasonal variation in psoriasis symptoms [Abstract] (2016) (0)
- Drug-induced liver injury (DILI) Amoxicillin-clavulanic acid HLA-DRB1*15:02 Major Histocompatibility Complex (MHC) Peptide-binding groove diagnostic genotyping Word count: 3458 Figures: 2 Tables: 2 Key Points: 1) Candidate gene and genome-wide association studies (GWAS) in well characterized cases h (2018) (0)
- Historical Archive Symposium (2011) (0)
- thetight junction protein claudin 7 is increased in photaged human epidermis (2010) (0)
- Professor Lionel Fry (1933-2021). (2021) (0)
- A potential role for oxygen in the photodegradation of fibrillin microfibrils by UVB radiation (2010) (0)
- 399 Risk of hospitalization due to infection in patients with psoriasis: A population-based cohort study using the UK Clinical Practice Research Datalink (2020) (0)
- Cerebel lopont ine angle epithel ial cyst . A case report (0)
- Summaries of papers (1995) (0)
- Proceedings of the Facial and Aesthetics Conference and Exhibition, Royal College of Physicians, London, 26-27 June. (2004) (0)
- Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities? (2023) (0)
- "What's new?" - An analysis of the clinical significance of new guidelines and systematic reviews found in the 2009 Annual Evidence Update on Psoriasis (2009) (0)
- Risk-benefit of new biologicals in the treatment of chronic plaque psoriasis (2006) (0)
- Interview: Advances in dermatology (2013) (0)
- Patient preferences for drug treatments for psoriasis: A discrete choice experiment. (2007) (0)
- Bioinformatic identification of potential sacrificial proteins in ageing tissues (2015) (0)
- Health care costs and life years gained from treatments within the ACTA trial on cryptococcal meningitis : a comparison of antifungal induction strategies in sub Saharan Africa (2018) (0)
- Ethnicity is a key determinant of skin structure and composition (2014) (0)
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege (2022) (0)
- 14 August 1965 Intradermal B . IC . G . Vaccination by Jet Injection (2007) (0)
- Magnetic resonance spectroscopy (MRS) to study chemotherapy response in a paediatric embryonal rhabdomyosarcoma (Rd) model. (2003) (0)
- CME Dermatology (100625): self-assessment questionnaire. (2016) (0)
- Newsletter ILDS No. 14 (2010) (0)
- Exploring psoriasis patients' experiences of CVD risk discussions with primary care practitioners: A qualitative study (2014) (0)
- Twenty top tips to triumph in dermatology (2012) (0)
- Liver X receptor beta is expressed in human epidermis but is not altered in aged skin (2008) (0)
- Apolipoprotein E (ApoE) single nucleotide polymorphisms (SNPs) and acitretin therapy in psoriasis. (2005) (0)
- In reply: Effects versus improvement of photoaged skin (2010) (0)
- Treatment attitudinal groups in patients with psoriasis using systemic treatments: findings from the Investigating Medication Adherence in Psoriasis study (iMAP). (2015) (0)
- Altered HPA axis response to acute social stress in patients with psoriasis (2005) (0)
- A survey of sleep disturbance in psoriasis [Abstract] (2016) (0)
- ‘Mind the gap’: what patients and clinicians believe is ‘unknown’ about psoriasis (2020) (0)
- Cutaneous immune responses to 2, 4-dinitrochlorobenzene (DNCB): role of interleukin (IL)-2 (97.15) (2009) (0)
- Phosphoinositide-mediated signal transduction in normal and psoriatic epidermis. (1990) (0)
- Further evidence for shared genetic architecture between psoriasis and Crohn's disease (2008) (0)
- Understanding treatment decision-making in people with psoriasis using the necessity-concerns framework (2011) (0)
- Bristol Cup Posters (2008) (0)
- Immediate global support is needed for Myanmar (2021) (0)
- Genes coding for dermal-epidermal junction proteins have altered expression with age (2013) (0)
- Examining patients' preferences for the treatment of psoriasis. (2005) (0)
- PSK1 EFFICACY OF BIOLOGICAL THERAPIES IN THE TREATMENT OF PSORIASIS: A META-ANALYSIS (2006) (0)
- characterisation of tight junction proteins in photoaged epidermis (2011) (0)
- Application of all-trans retinoic and regulates the activity of the lysyl oxidase family of crosslinking enzymes in photoaged skin (2014) (0)
- Ultraviolet-B irradiation modulates tight junction protein expression in cultured primary keratinocytes (2011) (0)
- O01: The impact of the COVID‐19 pandemic on people with psoriasis: findings from a global patient‐reported registry (2021) (0)
- Session 19: Clinical immunology of psoriasis (2004) (0)
- Histologic effects of topical retinoic acid (1995) (0)
- Long-term safety and tolerability of Apremilast in patients with psoriasis: pooled safety analysis of the ESTEEM 1 and 2 trials (2015) (0)
- 1030 Role of mast cells in psoriasis associated-pruritus (2018) (0)
- Comparison of intense pulsed light and laser treatment of telangiectases in systemic sclerosis (2012) (0)
- Are practitioners equipped to support lifestyle behaviour change in psoriasis patients? A qualitative study (2014) (0)
- Understanding health promotion signposting for people with psoriasis: The application of nudge theory (2014) (0)
- Psoriasis 2000: the state‐of‐the‐art today … and tomorrow (2001) (0)
- Reply (1986) (0)
- Scanning acoustic microscopy of biological cryosections: the effect of local thickness on apparent acoustic wave speed (2014) (0)
- 89. Influence of Immunogenicity on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab: A UK-Based Prospective Study (2014) (0)
- Viewpoint 2 (2008) (0)
- Environmental risk factors for the development of psoriatic arthritis: A case-control study (2005) (0)
- In situ ultrastructural imaging of native extracellular matrix macro-molecules (2010) (0)
- Secukinumab improves the quality‐of‐life of family members and partners of people with psoriasis: Family Dermatology Life Quality Index (FDLQI) results from a randomised open‐label study (SIGNATURE) (2022) (0)
- Efalizumab: A Viewpoint by Helen S. Young and Christopher E.M. Griffiths (2005) (0)
- Plain language summaries in Simplified Chinese (2017) (0)
- 317 Features of pustular psoriasis observed in 863 patients: Clinical and genetic analysis of a multi-ethnic cohort (2018) (0)
- Anti-aging Effects of Retinoids and Mechanisms of Action (2007) (0)
- Down-regulation of Langerhans cell protein kinase C-(3 isoenzyme expression in inflammatory and hyperplastic (1995) (0)
- Ultraviolet irradiation directly influences the structure of fibrillin microfibrils (2007) (0)
- So you want to be ... a dermatologist. (2009) (0)
- Visible Impact and Experiences of Health Professional Consultation: a Qualitative Study of People with Psoriasis (2011) (0)
- Polymorphisms in methotrexate efflux transporters have the potential to predict clinical response to methotrexate therapy in psoriasis. (2006) (0)
- 624 Clinical and immune analysis of mesenchymal stromal cells (MSCs) for multiple biologic-resistant psoriasis (2023) (0)
- Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis1 (2004) (0)
- Recognising Distress in Primary Care Consultations: A Qualitative Study of the Experiences of People with Psoriasis (2011) (0)
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis (2019) (0)
- The effect of smoking on matrix metalloproteinase activity in the skin (2009) (0)
- 001 Risk of serious infection associated with biologic therapies in psoriasis: A prospective cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2017) (0)
- Secukinumab’s pooled and long-term safety remains favorable up to five years of treatment in 19 psoriasis clinical trials (2018) (0)
- Topical retinoids for the ageing face (2002) (0)
- IXORA-S 1 Ixekizumab provides superior efficacy compared to u stekinumab over 52-weeks of 1 treatment : results from IXORA-S , a phase 3 study 2 (2018) (0)
- 1030 BELIEFS ABOUT SLEEP IN PEOPLE WITH PSORIASIS: AN IN-DEPTH QUALITATIVE STUDY USING THE COMMON-SENSE MODEL OF SELF-REGULATION FRAMEWORK (2017) (0)
- Completion of a pharmacogenetic screen of the methotrexate metabolic pathway (2007) (0)
- Genetic. Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis. Arthritis (2015) (0)
- Psychodermatology (2016) (0)
- All-trans retinoic acid influences the macromolecular structure of fibrillin microfibrils (2011) (0)
- Organisation of the dermal matrix impacts the biomechanical properties of skin Running head : Biomechanical properties of skin (2017) (0)
- Association analysis of the IL12B and IL23R genes in clinical variants of psoriasis (2007) (0)
- Treatment decision-making in people with psoriasis: An analysis using the Necessity-Concerns Framework. (2010) (0)
- "What's new?" An analysis of the clinical significance of new national guidelines and systematic reviews found in the 2008 Annual Evidence Update. (2008) (0)
- Expression of LOXL1 in intrinsically aged and photoaged skin (2011) (0)
- Exploring Healthcare Professionals’ Personal Models About Psoriasis: ‘we Understand but we Forget it’ (2014) (0)
- I should have taken that further’: a mixed methods study of missed opportunities in the cardiovascular risk assessment of patients with psoriasis (2014) (0)
- Immediate Global Support is Needed for the Myanmar Dermatology Community. (2021) (0)
- Are Dermatology Clinicians Trained to Deliver Behaviour Change in People With Psoriasis (2014) (0)
- Registrars' Symposium (2015) (0)
- 15308 Frequency of gastrointestinal-related serious adverse events among guselkumab-treated patients with moderate to severe psoriasis: A pooled analysis of Voyage 1 and Voyage 2 through 3 years (2020) (0)
- Plain language summaries in Simplified Chinese (2017) (0)
- 'I think of it primarily as a skin complaint': GPs’ perspectives on the management of psoriasis (2012) (0)
- Allergen-induced up-regulation of interleukin 2 (IL-2): Role in Langerhans’ cell (LC) migration (2008) (0)
- New biological response modifiers for inflammatory skin disease (2003) (0)
- Photosensitive psoriasis: clinical characteristics and potential role of memory effector T lymphocytes in the pathogenesis (2007) (0)
- Coping with Psoriasis: A Qualitative Study of Patients’ Self-Identified Coping Responses and Self-Care Strategies (2011) (0)
- The influence of smoking on the structure and function of cutaneous fibrillin microfibrils (2009) (0)
- Key Clinical Evidence - Dermatology: Dermatology (2009) (0)
- Abdominal wall thickening in a middle aged man (2000) (0)
- Alcohol-RelatedMortality in PatientsWith Psoriasis A Population-Based Cohort Study (2017) (0)
- An in vitro assay system for testing sunscreens (2013) (0)
- Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study (supplemental materials) (2020) (0)
- Book Review Dermatology Second edition. By Otto Braun-Falco, Gerd Plewig, Helmut H. Wolff, and Walter H.C. Burgdorf. 1853 pp., illustrated. New York, Springer-Verlag, 2000. $235. 3-540-59452-3 (2001) (0)
- WITHDRAWN: Interventions for guttate psoriasis. (2019) (0)
- Effects vs Improvement of Photoaged Skin—Reply (2010) (0)
- Cellular localization in human skin of retinoic acid induced cellular retinoic acid binding protein ii and nuclear retinoic acid receptor gamma 1 mrnas by non radioactive in situ hybridization (1992) (0)
- 评估萎缩性面部光损伤的光数字标准 (2018) (0)
- Analysis of IL12B and IL23R alleles in clinical variants of psoriasis (2008) (0)
- PASI 90 / 100 , DLQI 0 / 1 , and IL-17 Receptor / Cytokine : Does it Make a Difference and Are We Ambitious Enough ? (2018) (0)
- All-trans retinoic acid normalizes the periodicity of photoaged fibrillin microfibrils in vivo (2014) (0)
- Effects of biologic therapies on the severity of skin symptoms and quality of life in patients with plaque-type psoriasis: a meta-analysis. (2007) (0)
- Lesional Levels of Endothelial Cell Stimulating Angiogenesis Factor (ESAF) and Vascular Endothelial Cell Stimulating Angiogenesis Factor (VEGF) are Elevated in Psoriasis (1998) (0)
- Psychological and social impact of dermatological conditions. (2014) (0)
- Recognising distress in health care consultations: a qualitative study of people with psoriasis (2012) (0)
- Adherence in psoriasis: a systematic narrative review (2011) (0)
- Enumeration of the frequency of Langerhans cells in epidermis: reply from authors (2002) (0)
- Biological therapy for psoriasis and risk of cancer (2018) (0)
- Predicting the differential susceptibility of dermal extracellular matrix proteins to photodegradation by solar-simulated radiation (2012) (0)
- Alexithymia patients with psoriasis; clinical correlates and psychometric properties of the TAS-20 (2005) (0)
- Ethnic differences in dermal extracellular matrix (2013) (0)
- Low dose UVA challenge causes early histological abnormalities in uninvolved skin of patients with photosensitive psoriasis. (2006) (0)
- Combination regimens of topical calcipotriol in chronic plaque psoriasis: A systematic review of their efficacy and tolerability (2000) (0)
- A Qualitative Study of Supporting Lifestyle Behaviour Change in Psoriasis Patients – are Practitioners READY? (2014) (0)
- 018 Impact of biologic therapies on the quality of life of psoriasis patients: results from the British Association of Dermatologists’ Biologic Interventions Register (2016) (0)
- The Future of ESDR (2020) (0)
- Illness perception, psychological distress and quality of life in patients with cicatricial alopecias (2010) (0)
- 039 Systems biology approach to the analysis of pharmacogenomic data in psoriasis (2016) (0)
- AB0528 COMPARABLE SAFETY PROFILE OF GUSELKUMAB IN PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM PHASE 3 TRIALS THROUGH 1 YEAR (2021) (0)
- 115 The frequency of intermediate monocytes before treatment is a candidate biomarker of clinical response to secukinumab in of psoriasis (2022) (0)
- Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study (2019) (0)
- Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis (2014) (0)
- Dermatopathology Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis (2002) (0)
- Topical retinoic acid for photoageing: clinical use and mechanism of action (1995) (0)
- 344 Topical carbamide peroxide for treatment of mild to moderate acne vulgaris (2017) (0)
- 659 Identifying novel biomarkers of aging (2018) (0)
- Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study (2019) (0)
- 148 Increased skin viscoelastic creep following menopause is not driven by changes to the dermal elastic fibre network (2019) (0)
- Psoriasis: future drugs (2005) (0)
- 749 Impact of chronic sun exposure on the elastic fiber network of African-American and Caucasian skin (2017) (0)
- 331 Addition of interleukin-17 alters the healthy keratinocyte secretome and causes inhibition of Langerhans’ cell migration (2016) (0)
- Acute ultraviolet B-induced changes in epidermal tight junction protein expression are dependent on the differentiation state of keratinocytes. (2012) (0)
- 556 Advances in extracellular matrix proteomics through optimised sample preparation (2016) (0)
- Patterns of index biologic drug registrations to a pharmacovigilance register of psoriasis patients (2016) (0)
- Psoriatic Arthritis is Associated with A Greater Economic and Humanistic Burden Among Patients with Psoriasis: Results from A Multinational Physician and Patient Survey (2016) (0)
- Protease-mediated remodelling of the elastic fibre system of intrinsically aged skin (2010) (0)
- Disease Burden, Outcomes and Costs Among Adults Admitted To Hospital In The United Kingdom (Uk) Due to Plaque Or Erythrodermic Psoriasis. (2015) (0)
- A real-world comparison of drug discontinuation rates between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2018) (0)
- 微生物群对银屑病的作用:从疾病描述到治疗预测? (2018) (0)
- 510 Development and validation of a risk prediction model for serious infection in patients with psoriasis using the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018) (0)
- Completeness of reporting of basal cell carcinoma and squamous cell carcinoma to a pharmacovigilance register and the Health and Social Care Information Centre. (2016) (0)
- Risk of serious infections during use of biologic therapies for psoriasis: a systematic review (2016) (0)
- 304 Mass spectrometry based proteomic investigation of epidermal and dermal skin aging (2016) (0)
- 1277 Aging in skin of color: Organization of the dermal matrix impacts skin function (2018) (0)
- Rasch analysis of a new Patient Reported Outcome Measure for Psoriasis Treatment (PROMPT) (2015) (0)
- Evaluation of the IMPACT study practitioner training intervention: using motivational interviewing to optimize self-management in psoriasis (2016) (0)
- OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES (2022) (0)
- 537 Geographical ancestry influences the ultrastructure of papillary dermis-derived fibrillin-rich microfibrils (2016) (0)
- ?You have to prioritise your own role?: A qualitative investigation of clinicians? beliefs about supporting psoriasis patients with lifestyle management (2014) (0)
- Methotrexate polyglutamates are associated with response to treatment in psoriasis (2015) (0)
- 098 Retinoids in the treatment of skin photoageing: A histological study of topical all-trans retinoic acid efficacy in black skin (2019) (0)
- 610 Hibiscus abelmoschus seed extract induces remodelling of the papillary dermal fibrillin-rich microfibrils (2019) (0)
- Risk prediction model for serious infections in psoriasis (2019) (0)
- Main Plenary Sessions (2014) (0)
- Erratum: Retinoic acid metabolites exhibit biological activity in human keratinocytes. Mouse melanoma cells and hairless mouse skin in vivo (Journal of Pharmacology and Experimental Therapeutics (1993) 266 (1636-1642)) (1994) (0)
- Geographical ancestry influences fibrillin microfibril macromolecular structure (2014) (0)
- Improvements in health-related quality of life and symptoms of depression with tofacitinib: results from two randomized phase 3 studies in patients with moderate to severe psoriasis (2016) (0)
- Facial wrinkling and basal cell carcinoma. Authors' reply (2002) (0)
- International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries: Supplemental Appendix (2020) (0)
- A fresh look at T cells in psoriasis (2015) (0)
- P38: Machine learning methods for the prediction of treatment outcome in psoriasis: a systematic review (2022) (0)
- P37: Correlation of Psoriasis Disability Index and Psoriasis Area and Severity Index (2022) (0)
- Comprar Work in the 21st Century: An Introduction to Industrial and Organizational Psychology | Tony Burns | 9781405190251 | Wiley (2009) (0)
- The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. (2022) (0)
- Non-adherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. (2022) (0)
- An investigation of neuroinflammation in the brains of patients with psoriasis: a [11C]-(R)-PK11195 positron-emission tomography study. (2014) (0)
- Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes (2023) (0)
- Effects ofAll-Trans Retinoic AcidandCa''on HumanSkininOrganCulture (1993) (0)
- 359 Interleukin-17F expression in psoriasis and health (2019) (0)
- Evaluation of the eTIPs study (2011) (0)
- Multifaceted amelioration of cutaneous photoageing by (0.3%) retinol (2022) (0)
- The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study (2022) (0)
- Immunopathogenesis and immunotherapy of psoriasis : Psoriasis (1995) (0)
- Retinol elicits epidermal acanthosis and CRABP-II mRNA expression, but insignificant erythema when topically applied to human skin (1993) (0)
- P97: Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege (2022) (0)
- Main Plenary Sessions (2019) (0)
- Psychological distress in patients using systemic therapies for psoriasis: the role of beliefs about illness and anger suppression (abstract only) (2017) (0)
- The Manchester Skin Proteome (2017) (0)
- Adapalene 0.1% gel and 0.1% cream stimulate RAR mediated gene transcription without significant skin irritation in humans (1998) (0)
- A photonumeric scale for the assessment of atrophic facial photodamage (2018) (0)
- Obesity, low mood, negative beliefs about illness and severity of psoriasis are linked to dysfunctional eating patterns [Abstract] (2016) (0)
- 26874 Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial (2021) (0)
- Research Governance: What is reasonable protection? (2005) (0)
- 27043 Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate-to-severe psoriasis treated with guselkumab: 5-year data from VOYAGE 1 (2021) (0)
- Risk of incident cancer in psoriasis patients treated with biologics. Meta-analysis of nested case-control studies in Psonet registries.: Description of study and preliminary results (2017) (0)
- The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celebration of research collaboration in British dermatology (2020) (0)
- Immunopathology of "neutrophilic" primary cicatricial alopecias (2010) (0)
- Life threatening complications of dermatological therapy (2001) (0)
- P36: Dissecting the cellular landscape of hidradenitis suppurativa through single‐cell sequencing and spatial transcriptomics (2022) (0)
- Does the lifestyle of patients with psoriasis affect their illness? (2021) (0)
- Acute psychosocial stress downregulates N‐methyl‐d‐aspartate receptors in healthy human skin (2018) (0)
- Biologic therapies in dermatology. (2013) (0)
- Factors associated with hospitalization due to COVID-19 in patients with psoriasis: insights from a global registry (2020) (0)
- How do health professionals communicate risk during cardiovascular disease screening consultations (2014) (0)
- 021 WITHDRAWN (2016) (0)
- Cross-linking of structural proteins in ageing skin: an in situ assay for the detection of amine oxidase activity (2012) (0)
- Concordance and timing in recording cancer events in primary care, hospital and mortality records for patients with and without psoriasis: A population-based cohort study (2021) (0)
- ' s response to reviews Title : Do English Healthcare Settings Use ' Choice Architecture ' Principles in Promoting Healthy Living for People with Psoriasis ? An observational study (2015) (0)
- Is psoriasis associated with neuroinflammation (2014) (0)
- Characterisation of tight junction proteins in photoaged human skin (2011) (0)
- Tender facial nodules in a man receiving adalimumab for psoriasis (2021) (0)
- 013 WHO surgical checklist in dermatology: compliance, attitudes, barriers (2016) (0)
- The TARGET (TPMT: Azathioprine Response to Genotyping and Enzyme Testing) study (2005) (0)
- Contents, vol. 6, supplement 1, 1993 (1993) (0)
- Cardiovascular Disease Risk Communication in Patients with Psoriasis: A Qualitative Study (2012) (0)
- Environmental factors drive the cross-linking of structural proteins in ageing skin (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Christopher Griffiths?
Christopher Griffiths is affiliated with the following schools:
